These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Search MEDLINE/PubMed
Title: Mid-Term Results of Thoracic Endovascular Aneurysm Repair with Intentional Celiac Artery Coverage for Crawford Type I Thoracoabdominal Aortic Aneurysms with the TX2 Distal Component Endograft. Author: Fukushima S, Ohki T, Kanaoka Y, Ohta H, Ohmori M, Momose M. Journal: Ann Vasc Surg; 2020 Jul; 66():193-199. PubMed ID: 31778761. Abstract: BACKGROUND: Anatomically suitable Crawford type I (C-I) thoracoabdominal aortic aneurysm (TAAA) can be treated by thoracic endovascular aneurysm repair (TEVAR) with intentional celiac artery (CA) coverage to ensure distal seal. We report on mid-term results of TEVAR with intentional CA coverage for C-I TAAA. METHODS: Between August 2010 and July 2017, we treated 16 cases of C-I TAAA by TEVAR with intentional CA coverage using the Zenith TX2 Thoracic Distal Component Endograft. The primary end point was aneurysm shrinkage. Secondary end points were technical success, aneurysm-related death (ARD), and major adverse events (MAEs) including stroke, paraplegia, visceral ischemia, endoleak, and secondary intervention. RESULTS: The preoperative mean aneurysm size was 57.7 ± 8.0 mm. The technical success rate was 100%. There was no aneurysm-related mortality; however, one patient suffered from superior mesenteric artery embolization, which required an open laparotomy. The mean observational period was 40.5 months, and aneurysm shrinkage of >5 mm was observed in 10 cases (62.5%). At 12, 36, and 60 months after the procedure, freedom from ARD was 100%, 100%, and 100%, respectively, whereas freedom from MAE including secondary intervention was 86.7%, 86.7%, and 77.0%, respectively. CONCLUSIONS: Mid-term results of TEVAR with intentional CA coverage for C-I TAAA were acceptable.[Abstract] [Full Text] [Related] [New Search]